Previous Article | Next Article 
Journal of Virology, January 1999, p. 242-250, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Matrix Protein of Rabies Virus Is Responsible for the Assembly
and Budding of Bullet-Shaped Particles and Interacts with the
Transmembrane Spike Glycoprotein G
Teshome
Mebatsion,
Frank
Weiland, and
Karl-Klaus
Conzelmann*
Department of Clinical Virology, Federal
Research Centre for Virus Diseases of Animals, D-72076
Tübingen, Germany
Received 10 June 1998/Accepted 18 September 1998
 |
ABSTRACT |
To elucidate the functions of rhabdovirus matrix (M) protein, we
determined the localization of M in rabies virus (RV) and analyzed the
properties of an M-deficient RV mutant. We provide evidence that M
completely covers the ribonucleoprotein (RNP) coil and keeps it in a
condensed form. As determined by cosedimentation experiments, not only
the M-RNP complex but also M alone was found to interact specifically
with the glycoprotein G. In contrast, an interaction of G with
the nucleoprotein N or M-less RNP was not observed. In the absence of
M, infectious particles were mainly cell associated and the yield of
cell-free infectious virus was reduced by as much as 500,000-fold,
demonstrating the crucial role of M in virus budding. Supernatants from
cells infected with the M-deficient RV did not contain the typical
bullet-shaped rhabdovirus particles but instead contained long,
rod-shaped virions, demonstrating severe impairment of the virus
formation process. Complementation with M protein expressed from
plasmids rescued rhabdovirus formation. These results
demonstrate the pivotal role of M protein in condensing and
targeting the RNP to the plasma membrane as well as in incorporation of
G protein into budding virions.
 |
INTRODUCTION |
Matrix (M) proteins of
negative-strand RNA viruses constitute major structural components of
the virus and are believed to be required for virus assembly and
budding. For rhabdoviruses, the first insight into the function of
M protein was obtained by treating vesicular stomatitis virus (VSV)
with nonionic detergent and analyzing intact VSV
nucleocapsid-M complexes. Isolated subviral structures, which
were named skeletons, resembled intact virions, despite their
increased length and smaller diameter (3, 22). These
results suggested that the viral assembly function is due to the
ability of M to bind and probably condense the nucleocapsid (reviewed
in reference 14). Most importantly, skeleton-like structures were also observed near the plasma membranes of VSV-infected cells, showing that these structures represent an intermediate between
naked nucleocapsid and mature virions (24). VSV M has been
also shown to bind to the plasma membrane even in the absence of other
viral proteins, and such membrane-associated M was also able to bind to
the nucleocapsid of VSV in vitro (4, 5). These properties of
M protein make it likely that M functions in the viral assembly and
budding process by acting as a bridge between the nucleocapsid and the
plasma membrane.
In influenza virus, the matrix protein (M1) is proposed to surround the
nucleocapsid (26), and it was suggested that M1 interacts
with the membrane and perhaps also with the spike proteins. In
contrast, VSV M protein was suggested to be inside the
nucleocapsid coil and accessible to make contact with the lipid bilayer
only at the extreme ends (1). This is in contrast to the
more generally accepted view that M is responsible for the condensation
of the nucleocapsid from outside and that it is localized between the nucleocapsid coil and the membrane (33). For both VSV and
influenza virus, due to the lack of clear labeling with antibodies, no
conclusive data on the localization of M have been obtained.
The genome organization and virion structure of rabies virus (RV), the
prototype of the Lyssavirus genus within the family Rhabdoviridae, are highly similar to those of VSV. In both
viruses, the nonsegmented negative-strand RNA together with the
nucleoprotein (N), phosphoprotein (P), and polymerase (L) forms a
helical ribonucleoprotein (RNP) complex. In the virion, the RNP is
enwrapped by a lipid bilayer containing the single transmembrane spike
glycoprotein (G) and, ostensibly, the matrix protein (M). Although the
central role of M proteins of nonsegmented negative-strand RNA viruses in virus assembly and budding process appears to be obvious, direct experimental evidence for their functions has not been provided. This
was mainly due to the lack of systems that would allow direct genetic
manipulation of nonsegmented negative-strand RNA virus genomes. These
technical difficulties have been overcome by the development of reverse
genetics systems allowing recovery of viruses from cDNA, as first
described for RV (31), which are now being employed for
generation of nonsegmented negative-strand RNA virus mutants (reviewed in reference 9).
Recently, we have shown that spikeless rhabdovirus-shaped particles are
released from cells infected with a G-deficient mutant, albeit at a
30-fold lower efficiency (21). This demonstrated that RNPs
associated with M protein can be enwrapped with a membrane and bud
at the cell surface. For VSV, it was shown that M is able to induce
budding of vesicles in the absence of other VSV proteins (13,
15), indicating that M protein is able to pinch off membranes autonomously. Apart from M protein, rhabdovirus G proteins were also shown to contribute to the budding efficiency and even to be able
to mobilize RNAs or RNPs (21, 25). Therefore, highly efficient budding of rhabdoviruses is achieved by a concerted action of
both spikes and cores.
Another role of M protein in virion formation is its involvement in
virion morphogenesis. It was shown that spherical particles were
released from cells infected by a temperature-sensitive M mutant of VSV
at the nonpermissive temperature (16). In addition, the
involvement of M in determining the formation of spherical or
filamentous particles was documented for influenza viruses (34), suggesting a pivotal role of M protein in virion morphogenesis.
Apart from their roles in virus assembly and budding, M proteins of
rhabdoviruses, influenza viruses, and paramyxoviruses were reported to
inhibit viral transcription (2, 6, 12, 18, 35, 37).
Subgenomic mRNAs of these groups of viruses are transcribed from RNPs
which also serve as templates for the replication of full-length RNAs.
In an in vitro transcription assay with isolated RNPs and M protein
of VSV, the transcription inhibition activity of the M protein was
shown to be due to reassociation of M protein with RNP cores
(2).
In this report, based on biochemical studies and reverse genetics
approaches, we show the localization of M protein in mature RV and
describe properties of an RV mutant lacking the entire M gene. The
results demonstrate that M lies between the lipid bilayer and the RNP
coil and that in the absence of M protein the virus assembly and
budding process is severely impaired. Characterization by
electron microscopy showed poor release of only rod-shaped particles or
round vesicular structures but no bullet-shaped viruses. Subsequent expression of M protein from plasmid DNA in cells
infected with the M-deficient mutant rescued high titers of
infectivity and resulted in the release of typical bullet-shaped
particles, demonstrating that RV M protein is responsible for the
formation of virions with a bullet-like morphology. Moreover, we
provide evidence for a direct interaction of G protein with M.
 |
MATERIALS AND METHODS |
Detergent treatment of virions and immunoelectron
microscopy.
Approximately 106 and 107 BSR
cells were infected with SAD L16 and SAD
M, respectively, at a
multiplicity of infection (MOI) of 1. Approximately 5 × 108 SAD L16 virions were treated with either 0.05% Triton
X-100 or 20 mM octyl-glucoside for 15 min at room temperature.
Detergent-treated or untreated control samples were fixed with 0.5%
glutaraldehyde for 30 min at 4°C and purified by centrifugation
through 20% sucrose on a 60% sucrose cushion in a Beckman SW41 rotor
at 27,000 rpm for 90 min. The interphase was then collected by side
puncture. Carbon-coated nickel grids were deposited for 7 min on a drop of the virus suspension and washed four times with phosphate-buffered saline (PBS) containing 0.5% bovine serum albumin. Samples were incubated for 45 min with anti-RV G monoclonal antibody (MAb) E543
(27), a monospecific anti-M polyclonal rabbit serum (S66), or a rabbit serum raised against purified RV RNP (S50), recognizing RV
N and P proteins (21). Immunostaining was performed by
incubating the samples with goat anti-mouse or goat anti-rabbit
immunoglobulin G antibody (Biocell, Cardiff, United Kingdom) coupled to
10-nm gold particles. After being washed with PBS and distilled water, the samples were negatively stained with 1% uranyl acetate
(unbuffered) and examined in a Zeiss 109 electron microscope.
Micrographs were taken at an instrumental magnification of ×50,000 on
Agfa Scientia 23D56 film.
Construction of a cDNA clone.
To delete the entire M
protein-coding region from the RV genome, the following
manipulations were performed with the full-length cDNA clone pSAD L16
(31), which possesses the authentic sequence of the RV
strain SAD B19 (7). First, subclone pSKpm24, containing a
2.7-kb EcoRI-XhoI fragment of pSAD L16,
representing SAD B19 nucleotides 1112 to 3823, was generated. By
digestion of pSKpm24 with PflMI and XbaI,
subsequent filling in by Klenow enzyme, and religation, a cDNA fragment
comprising SAD B19 nucleotides 2435 to 3176 was removed. A
BstBI fragment of the modified pSKpm24 (SAD B19 positions
1498 to 3739) was then isolated and used to replace the corresponding
fragment of pSAD L16 to give rise to pSAD
M.
Recovery of M-deficient RV.
Transfection experiments were
carried out as described previously (10). Approximately
106 BSR cells were infected with the recombinant vaccinia
virus vTF7-3 (11) and then transfected with a plasmid
mixture containing 5 µg of pT7T-N, 2.5 µg of pT7T-P, 2.5 µg of
pT7T-L, 2 µg of pT7T-M, and 4 µg of pSAD
M by using the
Stratagene mammalian transfection kit (CaPO4 protocol).
Isolation of the transfectant virus and removal of vaccinia virus were
carried out as described previously (31). For passage of SAD
M, which required complementation with M protein to be
effective, cells were incubated with the clarified supernatant,
infected with vTF7-3, and transfected with 2 µg of pT7T-M as
described above. For detection of replicating RV, infected cells were
fixed with 80% acetone and stained with a conjugate containing a
mixture of MAbs directed to RV N protein (Centocor). Stocks of
phenotypically complemented SAD
M were prepared after seven or eight
serial passages. Infectious titers of RV and M-complemented SAD
M
were determined by serial 10-fold dilution and staining of infected
foci or syncytia with the N conjugate. For noncomplemented SAD
M,
the undiluted supernatant was used for infection of cells, and
fluorescent syncytia were counted at 24 h postinfection.
Analysis of RNA and RT-PCR.
Total RNA isolated from infected
cells was electrophoresed on denaturing gels and analyzed by Northern
hybridizations as described previously (8). RV N or M gene
cDNA fragments were labeled with 32P by nick translation
(Amersham nick translation kit). Reverse transcription-PCR (RT-PCR) was
performed on 1 µg of total RNA from infected cells. Reverse
transcription by avian myeloblastosis virus reverse transcriptase was
primed by an RV P gene-specific oligonucleotide, NS1P
(5'-GTCGAATCCGACAAGCTG-3'; SAD B19 nucleotides 2345 to
2362). DNA amplification was done with primer NS1P and a G
gene-specific primer, G4M (5'-GGGTACAAACAGGACAGC-3'; SAD B19 nucleotides 3329 to 3346), or an M gene-specific primer, M4M
(5'-TTGCAATCCGACGAACTC-3'). The PCR products resulting from
30 cycles (denaturation for 30 s at 94°C, annealing for 60 s at 45°C, and elongation for 120 s at 72°C) were analyzed on
1% agarose gels and used directly for sequencing.
Metabolic labeling and immunoprecipitation of proteins.
For surface immunoprecipitation, approximately 106 BSR
cells were infected with recombinant RVs at an MOI of 1. After 16 h of infection, cells were labeled with 100 µCi of
[35S]methionine (1,365 Ci/mmol; ICN) for 3 h. The
labeled cells were then incubated with a MAb directed to RV G
protein for 45 min at 4°C. Antigen extraction and
immunoprecipitation were performed as described previously
(21). Immunoprecipitated proteins were analyzed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
quantitated with a phosphorimager (Fuji BAS1500).
Sucrose gradient centrifugation and protein analysis.
For analysis of cell-free virions, approximately 106 and
107 cells were infected with SAD L16 and SAD
M,
respectively, at an MOI of 1. For velocity centrifugation, supernatants
were collected at 2 days postinfection and layered on 5 to 25%
sucrose gradients prepared in TEN buffer (10 mM Tris [pH 7.4],
50 mM NaCl, 1 mM EDTA). The gradients were centrifuged at 31,500 rpm in
an SW41 rotor for 30 min. To analyze the protein composition of
cell-associated infectious particles, equal amounts of infected cells
were washed five times with PBS and harvested by scraping the monolayer
in TEN buffer, pH 7.4. Cells were disrupted by sonication for 10 s
at 100 W with a Sonifier B12 (Branson Sonic Power Company), and the
lysates were clarified by centrifugation at 5,000 × g for 5 min at 4°C. For isopycnic centrifugation, clarified cell lysates or supernatants containing released particles were layered over
10 to 70% continuous sucrose gradients and centrifuged in an SW41
rotor at 35,000 rpm for 18 h. Equal amounts of 12 fractions were
collected, and an aliquot from each fraction was used to determine the
refractive index and the titer of infectious particles by end point
dilution. Virus proteins from gradient fractions were resolved by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred
to nitrocellulose membranes, and incubated with a mixture of rabbit
sera directed against RV proteins as described previously
(21). Proteins were visualized after incubation with peroxidase-conjugated goat anti-rabbit immunoglobulin G (Dianova) by
using the ECL Western blot detection kit (Amersham) (1-min incubation)
and exposure to X-ray films (Biomax MR; Kodak).
 |
RESULTS |
RV M is located beneath the lipid bilayer and surrounds the
RNP.
The virtual dogma that matrix proteins underlie the viral
lipid bilayer was recently challenged by results obtained in
electron microscopic studies of VSV, the prototype
rhabdovirus. It was suggested that VSV M is inside the RNP
coil and that only the part of M that protrudes from the RNP ends is
able to contact the lipid bilayer (1). To determine the
localization of M in RV virions, supernatants from infected-cell
cultures were harvested 24 h after infection, treated with
detergent, and fixed with glutaraldehyde. Virions were then purified
over sucrose gradients. Electron microscopic examination of untreated
control samples which were incubated with a monospecific anti-M
polyclonal rabbit serum did not show labeling on the outer surface,
confirming that M protein does not protrude through the virus
membrane (Fig. 1A). Treatment of virions
with 0.05% Triton X-100 removed the lipid bilayer together with the
surface transmembrane glycoprotein and resulted in subviral structures with the same lengths as intact RV but with smaller diameters (50 to 60 nm) than intact RV (90 to 100 nm) (Fig. 1). Similar
structures of VSV that was treated with octyl-glucoside have been named
skeletons (3), and we also use this term for the subviral RV
structures obtained after treatment with Triton X-100. The shapes of
the structures observed ranged from intact skeletons with residual
lipid bilayers (Fig. 1B) to partially disassembled ones in which RNP
extended out of the skeleton (Fig. 1D). This heterogeneity helped us to
determine the locations of virus proteins in the different
structures. By using an anti-G MAb, no gold labeling of skeletons was
detected, except for areas where the lipid bilayer was not completely
removed (Fig. 1B). To analyze the localization of M protein in the
subviral structure, the treated particles were labeled with the
monospecific anti-M serum and examined by electron microscopy.
Intensive labeling of intact skeletons was observed in areas completely
devoid of membranes, demonstrating that RV M lies beneath the lipid
bilayer and covers the nucleocapsid (Fig. 1C). In partially
disassembled skeletons, M labeling was not detected on the uncoiled
RNP, except at the unravelling ends of skeletons (not shown).
Incubation of such partially disassembled skeletons with a rabbit serum
raised against purified RNP resulted in intense labeling of the unwound nucleocapsid, but no gold labeling was observed on the surface of the
intact skeleton (Fig. 1D). Obviously, RV M protein covers the
entire surface of condensed RNPs. Even upon removal of the membrane, M
protein is associated with the nucleocapsid and maintains it in a
compact form. Upon partial removal of M, the RNP coil is released at
one or both ends of the skeleton (Fig. 1D). Intensive treatment with
the detergent resulted in a complete disassembly of the skeleton
structure (not shown), demonstrating that M protein imposes a
definite shape by maintaining the condensation of the RNP coil.

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 1.
RV M protein is positioned between the lipid bilayer
and the RNP coil. Virions treated with Triton X-100 (B to D) and
untreated control samples (A) were purified as described in Materials
and Methods and analyzed by electron microscopy. The absence of anti-M
labeling on the outer membranes of untreated virions (90 to 100 nm in
diameter) (A) and an intense anti-M labeling on the surfaces of the RNP
coil or skeletons (50 to 60 nm in diameter) of detergent-treated
virions (C) demonstrate that M surrounds the RNP coil. Only areas where
the lipid bilayer was not completely removed (60 to 70 nm in diameter)
are weakly labeled with anti-G MAb (B). In partially disassembled
skeletons (D), only the uncoiled nucleocapsid, and not the surface of
the skeleton, is labeled with anti-RNP serum. Bar, 100 nm.
|
|
Generation of an M-deficient RV mutant.
Analysis of
genetically engineered viruses that are completely devoid of a
particular gene and the ability to trans complement the
essential functions have proved useful in investigating the roles of
viral proteins. In order to address the functions of RV M
protein in virion formation, we constructed a cDNA in which the
entire RV M gene sequence (SAD B19 positions 2435 to 3176) was deleted
(Fig. 2). To rescue the modified cDNA
into virus, we used a previously described system (31) in
which T7 RNA polymerase transcripts corresponding to RV antigenome
RNA are assembled into transcriptionally active RNPs in cells that
express RV N, P, and L proteins. Not unexpectedly, it was not
possible to recover infectious M-deficient virions by using the
standard protocol, indicating severe impairment of virus formation in
the absence of M protein. We therefore complemented the defects
during recovery experiments by expression of M protein. In addition
to the plasmids encoding RV N, P, and L proteins and the antigenome
of the M-deficient mutant (SAD
M), cell cultures were transfected
with pT7T-M, encoding the SAD B19 M protein (10). After
incubation for 2 days, the presence of virus was detected by direct
immunofluorescence with an anti-N conjugate. Stocks of cell-free
phenotypically complemented SAD
M were prepared after seven or eight
passages in cells transiently expressing RV M protein from
transfected plasmids. The recombinant vaccinia virus vTF7-3 expressing
T7 RNA polymerase was then removed from the resulting supernatant by
filtration.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
Organization of the M-deficient RV genome. The entire RV
genome with its five open reading frames (top), a detailed M cistron
region (middle), and the region encompassing a deletion (bottom) are
shown. Arrowheads and bars represent transcriptional start and stop
signals, respectively. In SAD M, the entire M cistron (SAD L16
nucleotides 2435 to 3176) was removed by a deletion starting within the
nontranslated region of the P gene and ending close to the
transcriptional stop signal of the M gene.
|
|
To first confirm the absence of the M gene in SAD

M, total RNA was
isolated from cells infected with phenotypically complemented
SAD

M
virions, and RT-PCR was performed. By using the P gene-specific
primer
NS1P and the G gene-specific primer G4M, DNA fragments
of ~990 and
~250 bp were obtained from the genomes of SAD L16
and SAD

M,
respectively (not shown). The size difference of ~740
bp
corresponded to the deletion introduced into the cDNA. In addition,
by using primer NS1P and an M gene-specific primer, M4M, a DNA
fragment
of ~600 bp was obtained from the genome of SAD L16, but
no product
from the SAD

M genome was detected. The identity of
the recombinant
SAD

M virus was further verified by sequencing
the PCR products and
by Northern blotting of total RNA from cells
infected with SAD

M or
SAD L16. With a probe spanning the entire
coding region of the
RV M gene, no hybridization of SAD

M RNAs
was observed in
Northern blots, once again confirming the absence
of the M gene
(not shown). As determined with a phosphorimager,
approximately twofold more N mRNA was reproducibly present in
SAD

M-infected cells than in SAD L16-infected cells, which might
in
part reflect alleviation of the transcription-inhibitory activity
of
rhabdovirus M protein (
2,
6,
12).
SAD
M induces increased cell-cell fusion.
To investigate
the growth characteristics of SAD
M in the absence of RV M
protein, cells were infected with phenotypically complemented SAD
M virions at an MOI of 1 and examined by immunofluorescence at
various times after infection. Interestingly, cells infected with SAD
M showed a marked cell-cell fusion activity already after 24 h
postinfection. In contrast, cells infected in parallel with SAD L16
appeared unchanged even until 72 h of infection. To analyze this
unexpected effect of SAD
M, infection was done at a lower MOI
(0.005), and both live and fixed cells were examined for morphological
changes and viral protein expression. As shown in Fig.
3A, increased cell-cell fusion was
observed in SAD
M-infected cells at 48 h postinfection. Fused
cells started to detach from the monolayer and float in the supernatant
at 72 h postinfection. In contrast, cells infected with the
wild-type virus did not show much alteration even at 72 h of
infection.

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 3.
SAD M induces increased cell-cell fusion and cell
death. (A) Following infection of cultures with an MOI of 0.005, live
cells were examined microscopically for morphological changes at the
indicated times. Cell fusion is detected in SAD M-infected cells
after 48 h, and large syncytia are present at 72 h
postinfection. (B) In cells infected in parallel, the spread of
infection was monitored at the indicated times by direct
immunofluorescence with a conjugate directed against RV N protein.
Secondary infection of cells, as indicated by the appearance of
fluorescing granules, is virtually absent in SAD M. After 48 h,
SAD M N expression is found in large syncytia.
|
|
To compare the spreads of SAD

M and SAD L16, infected-cell cultures
were fixed with acetone and examined by direct immunofluorescence
with
an anti-N conjugate (Fig.
3B). In cultures incubated with
SAD L16,
primary infection of single cells spread to neighboring
cells within
24 h, as indicated by the appearance of small fluorescent
granules. Large foci of approximately 50 to 100 fluorescing cells
were
observed at 48 h postinfection, and the entire cell monolayer
was
infected at 72 h. In contrast, the typical small fluorescent
granules of early RV infection were entirely absent at 24 h
postinfection
in cultures incubated with SAD

M. At 48 h after
infection, cells
expressing RV N protein were found to fuse with
neighboring cells
and to form large multinucleated syncytia, which is
not a characteristic
property of a standard RV infection. At 72 h,
these syncytia start
to break into small pieces and either remain on
the monolayer
or float in the supernatant (Fig.
3).
G protein accumulates to high levels on the surfaces of cells
infected with SAD
M virus.
Previous results obtained with a
G-deficient RV mutant showed that infection of cells with supernatant
virus and cell-to-cell spread of RV absolutely depend upon the presence
of the G protein (21). Since the rate of intracellular
transport and accumulation of the G protein at the cell surface may
affect the growth characteristics of RV, cells infected with SAD
M
and SAD L16 were analyzed for the amount of G protein expressed at
the cell surface. After 16 h of infection, cells were labeled with
100 µCi of [35S]methionine for 3 h, incubated with
an anti-G MAb, and analyzed by surface immunoprecipitation (Fig.
4). As quantitated with a phosphorimager,
the total amount of G protein in SAD
M-infected cells was only
3% more than that in SAD L16-infected cells. However, the amount of G
protein present on the surfaces of infected cells was 2.6-fold more
for SAD
M-infected cells. The cell surface G was 13 and 33% of the
total G content for SAD L16 and SAD
M, respectively. Since G is the
only RV protein that has a fusion activity, the enhanced cell
surface accumulation of G protein may be responsible for the
increased cell-cell fusion in SAD
M-infected cells.

View larger version (76K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of cell surface expression of G proteins.
Approximately 106 BSR cells were infected at an MOI of 1 and after 16 h were labeled with 100 µCi of
[35S]methionine for 3 h. Anti-G MAb was incubated
with live cells to bind G proteins expressed at the cell surface or
with cell lysates containing total G protein. Phoshorimager
quantitation revealed a 2.6-fold-higher level of G protein on the
surfaces of cells infected by SAD M.
|
|
M is the driving force in virus assembly and budding.
The
characteristic pattern of spread observed for SAD
M in cell culture
and the high-level accumulation of G protein on the surfaces of SAD
M-infected cells suggested a defect in the virus assembly and
budding process. To determine the efficiency of virus formation and
release, noncomplementing cells were infected at an MOI of 1 with
phenotypically complemented SAD
M virions. The supernatants as well
as cell extracts were titrated at 24, 48, and 72 h after
infection. Compared to that of SAD L16, the total amount of infectious
SAD
M, including both cell-associated and cell-free virus, was
reduced by factors of approximately 600 at 24 h and 10,000 at
48 h postinfection (Table 1). When
only the titers of cell-free infectious virus were compared, the yield was reduced by as much as 5 × 105-fold. In agreement
with this, 98% of SAD
M infectious particles were found to be cell
associated, compared to fewer than 10% for the wild-type virus, at
48 h postinfection. This indicated severe defects in the virus
assembly and budding mechanism in the absence of M protein (Table
1).
Physical characteristics of infectious SAD
M particles.
To
analyze the sedimentation rate of the infectious particles,
supernatants from cells infected with SAD
M were layered on a 5 to
25% continuous sucrose gradient and centrifuged at 31,500 rpm in an
SW41 rotor for 30 min. Twelve equal fractions were collected from the
gradient, and the infectivities of individual fractions were determined
by end point dilution. For wild-type RV, the peak of infectivity was in
fractions 9 and 10 (numbering is from the top to the bottom of the
gradient), whereas for SAD
M, the majority of infectious particles
were found in two distinct peaks, encompassing fractions 7 and 8 and
fraction 11. This result indicated that the size of SAD
M particles
differs considerably from that of wild-type RV. To determine the
density of the infectious SAD
M particles, samples were sedimented
to equilibrium on 10 to 70% continuous sucrose gradients, and the
infectivities of 12 equal fractions were determined as described above.
The densities of the fractions containing the majority of infectious
SAD
M and SAD L16 were found to be 1.17 and 1.16 g/cm3, respectively.
RV M interacts with G.
An interaction between G and M and/or N
has been postulated to be required for efficient budding of
rhabdoviruses (17, 21). However, there was little direct
evidence in support of this central dogma. The analysis of the SAD
M
mutant was therefore expected to give clues as to whether G interacts
with M, N, or the RNP. Since most SAD
M infectious particles are
cell associated, we analyzed the protein composition and
infectivity of cell-bound particles after equilibrium centrifugation on
sucrose gradients. Total cell lysates were prepared as described in
Materials and Methods, layered on a 10 to 70% sucrose gradient, and
fractionated as described above. The locations of virus proteins
were determined by Western blotting, and the infectivities and
refractive indices of individual fractions were determined. The
majority of cell-associated infectious SAD L16 virions were
localized in fraction 6 (2 × 106/ml), which also
contained the largest amount of virus proteins (Fig.
5). The infectivity of cell-bound SAD
M also peaked in fraction 6 (1.5 × 103/ml), which
has a density of 1.14 g/cm3. Another protein peak in
both gradients in which mainly N was detected was localized in fraction
9 for SAD L16 and in fractions 9 and 10 for SAD
M. The density of
1.21 g/cm3 for fraction 9 in both gradients is identical to
the density of RV RNPs obtained after detergent treatment of purified
virions (21).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 5.
Protein composition of cell-associated SAD L16 and
SAD M virions. Cell extracts from approximately 106
infected cells were prepared as described in Materials and
Methods and purified by 10 to 70% sucrose gradient centrifugation.
Twelve equal gradient fractions (numbered from top to bottom) were
analyzed by Western blotting for the presence of viral proteins. The
sucrose density was determined from the refractive index of each
fraction. For both preparations, the peak of infectivity was present in
fraction 6, which has a density of 1.14 g/cm3.
|
|
A striking difference between the two gradients was in the proportions
of N protein localized in the two peaks (Fig.
5). While
the N
protein in fractions 5 and 6, where G is also colocalized,
in the
SAD L16 gradient constitutes 36% of the total N protein,
only 6%
of the SAD

M N protein is localized in the corresponding
fractions. The lack of colocalization of the SAD

M RNP with G
protein indicated that only those RNPs enwrapped by M protein
are able to specifically interact with the spike protein. To
investigate
whether M alone can interact with G or whether formation of
an
M-RNP complex is necessary, we expressed RV M, N, and G proteins
either alone or in combinations and analyzed cell lysates by
sedimentation
on sucrose gradients. When M protein was
expressed in the absence
of other viral proteins, about 10% of M
remained within the top
three fractions of the gradient, whereas
more than 90% moved towards
the bottom of the gradient and
peaked in fractions 6 and 7 (Fig.
6).
When G was expressed alone, the majority of G was localized
in
fractions 3 to 5. Most interestingly, when M and G were coexpressed,
the localization of M remained unaltered, but G followed M and
colocalized with it throughout the gradient, except at the top.
In
contrast, the distribution pattern of G remained unchanged
when it was
coexpressed with N protein, suggesting the absence
of a direct G-N
interaction. These results indicated that M is
able to interact with G
even in the absence of other viral components
and also in the form of
an M-RNP complex (Fig.
5). Obviously,
the interaction between G and the
RNP-M complex is crucial for
efficient budding of infectious progeny
virions.

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 6.
RV M interacts with G. Approximately 106 BSR
cells were first infected with vTF7-3 and then transfected with 5 µg
of plasmid DNA. After 16 h of infection, cell lysates were
prepared, centrifuged to equilibrium, and analyzed as described for
Fig. 5. (A) Density gradients from cells expressing G, N, or M protein
individually; (B) cells coexpressing G and N proteins or G and M
proteins. When G and M proteins were coexpressed, the G protein
cosedimented with M protein (numbering is from the top to the bottom of
the gradient).
|
|
M renders RV bullet shaped.
As shown above, the infectious
particles produced in SAD
M-infected cells varied in many respects
from wild-type RV. To analyze the morphology of the infectious
particles released in the absence of M protein, supernatant samples
were fixed with 0.5% glutaraldehyde and purified over a sucrose
gradient. Samples were incubated with a MAb directed against RV G
protein, stained with a secondary antibody coupled to colloidal
gold, and examined by immunoelectron microscopy. Although control
samples prepared in parallel from SAD L16-infected cells contained
almost exclusively typical bullet-shaped particles, we repeatedly
failed to detect even a single bullet-shape particle in samples
prepared from SAD
M-infected cells. Instead, the latter samples
contained either unique long, rod-shaped particles with smaller
diameters or rounded, vesicular structures (Fig. 7A to
C). The long, rod-shaped particles that
were found exclusively in the supernatants of cells infected by SAD
M varied greatly in size, ranging from 500 to 1,000 nm by 50 nm,
compared to 200 to 300 nm by 95 nm for wild-type RV. Both types of
particles were labeled with anti-G MAb, showing that they contain spike
G protein on their surfaces. Due to the high accumulation of G
protein on the surfaces of SAD
M infected cells, the particles
may have acquired G protein nonspecifically. Attempts were
also made to visualize SAD
M virions budding from the
surfaces of virus-infected cells by examining thin sections in the
electron microscope. However, we failed to detect any virus-like
particle budding at the plasma membrane, further confirming that in the
absence of M, RNPs alone are not competent for budding, even at
G-containing membranes.

View larger version (144K):
[in this window]
[in a new window]
|
FIG. 7.
Morphology of particles released from SAD M-infected
cells. SAD M was grown in the absence of RV M protein (A to C)
or in cells that express RV M protein from transfected plasmids
(D). Purified supernatants from approximately 107 SAD
M-infected BSR cells were immunostained with a MAb specific for the
RV G protein and analyzed by electron microscopy. In the
absence of RV M protein, either long rod-shaped particles (A and B)
or round vesicular structures (C), but no bullet-shaped particles, were
detected. After expression of RV M protein, the majority of
particles had the typical bullet-shaped rhabdovirus morphology (D).
Bar, 100 nm.
|
|
To confirm the possibility of correcting the observed defects in the
assembly and budding process of the SAD

M RV mutant,
we complemented
the M deficiency by expressing RV M protein in
infected
cells. The resulting supernatant was analyzed for infectivity
by
end point dilution and for particle morphology by electron
microscopy
as described above. After complementation of SAD

M,
the infectious
particle yield at 24 h posttransfection was increased
approximately 10,000 fold, from 10
2/ml (SAD

M) to
10
6/ml (SAD

M plus M), thus reaching 1% of the maximal
SAD L16 titers.
This indicated alleviation of the major defects by M
protein provided
in
trans. Moreover, the increase in
titer in the supernatant was
accompanied by the formation of typical
bullet-shaped particles
(Fig.
7D). Although round vesicular structures
were still present
in smaller number, the long rod-shaped particles
were virtually
absent in the supernatants after complementation with M
protein
from transfected plasmids. Taken together, these results
show
the absolute requirement of rhabdovirus M protein for
efficient
virus assembly and budding and for the bullet-like
morphology.
 |
DISCUSSION |
In the assembly pathway of negative-strand RNA viruses, the steps
following encapsidation of the RNA genome by nucleoprotein and finally resulting in the budding of mature viral particles are
believed to involve the matrix (M) protein. However, knowledge about the biological functions of M protein is restricted mainly to
membrane- or nucleocapsid-binding properties (reviewed in reference 14), and more direct evidence that M protein
does execute virus assembly and budding was not available. Recently,
the M protein of VSV, the prototype rhabdovirus, was reported to be
localized within the RNP coil (1), challenging the general
view of how M proteins contribute to virus assembly. In this work,
we show the localization of M protein in RV virions and describe a
recombinant mutant RV that lacks the entire M gene. Characterization of
this helper virus-free, M-deficient mutant provided greater insight into the role of M protein in the different steps of virus
formation, including virus protein assembly, morphogenesis, and
release of mature virions.
To determine the localization of M protein in mature RV in order to
understand how it exerts its action in the various steps of virion
formation, the membranes of mature virions were peeled off by using a
nonionic detergent. After immunogold labeling of the resulting subviral
structures, an intense anti-M gold labeling was seen on the surface of
the intact coiled nucleocapsid, the so-called skeleton. In
contrast, anti-RNP label was bound only to uncoiled RNP extending from
skeletons and not to the surfaces of intact skeletons. Both the intense
M labeling of intact skeletons and their inaccessibility to N and P
antibodies indicate that the RNP coil is completely covered with M
protein. Removal of M protein from skeletons apparently results
in uncoiling of RNP, which then can be labeled by anti-RNP antibodies.
Thus, the M protein layer surrounding skeletons is responsible for
keeping the RNP in the condensed form. The integrity and shape of the RV skeleton are therefore defined by the condensing effect of the M protein.
The finding that RV M lies beneath the lipid bilayer and surrounds the
RNP contradicts the results published for VSV (1). M
protein of VSV was suggested to be only inside the
nucleocapsid coil and to be able to interact with the membrane only at
the extreme ends. The absence of anti-M labeling on the surfaces of VSV
skeletons may be due to conformational differences between VSV M inside
the RNP coils and VSV M that might surround the RNP, so that epitopes
of the latter perhaps were not accessible to the antibodies used.
Alternatively, M protein outside the RNP coil may be rapidly
removed under the conditions used, while that inside may be more
resistant and sufficient to keep the skeletons condensed. However, a
significant difference in the structural organizations of the two
rhabdoviruses cannot be excluded (see below). In fact, in contrast to
the case for RV, we could also observe central structures resembling
the described cigar-shaped core (1) in partially uncoiled
VSV RNPs (not shown).
To elucidate the importance of RV M protein in virion formation, we
generated the RV mutant SAD
M, which lacks the entire M gene. The
mode of spread of SAD
M in cell culture was significantly different
from that of wild-type RV. SAD
M-infected cells showed an increased
cell-cell fusion and enhanced cell death, in contrast to the
noncytopathic type of growth of wild-type RV in cell culture. When
infection was done at a low MOI (0.005), the formation of giant
multinucleated cells was more evident. Such syncytia reach the maximum
size at 48 h postinfection and then start to disintegrate. Although RV is a rather noncytopathogenic virus, higher accumulation of
RV G protein in infected cells was reported to be associated with
increased cytopathic effects in fibroblasts and RV-induced apoptosis in
lymphocytes (23, 36). Thus, the 2.6-fold higher level of G
protein expression on the surfaces of cells infected by SAD
M
compared to SAD L16 may explain the increased cell-cell fusion and
cytopathic effects observed in SAD
M-infected cultures. In addition,
the high-level accumulation of G on the surfaces of SAD
M-infected
cells strongly suggests low-level depletion of surface G by budding virions.
The findings that the total amount of infectious SAD
M particles was
decreased by up to 10,000-fold and that of cell-free particles
was decreased by as much as 5 × 105-fold revealed
severe defects in the virus formation process if M protein is
not present. As shown by the density gradient centrifugation of
cell-associated infectious particles, the middle peak in the SAD L16
gradient accounted for 36% of the total RNP, compared to only 6% of
the corresponding SAD
M RNP (Fig. 5). Fraction 6 in both gradients
contained the majority of infectious particles and presumably the
majority of condensed RNP-M cores in the SAD L16 gradient. Such
condensed RV RNP-M cores were demonstrated to be able to bud at
the cell surface and mature into spikeless particles (21).
Thus, the considerable drop in SAD
M infectious particle
formation is mainly due to the absence of RNP-M cores, which may
represent the minimum budding-competent subviral structure. Presumably, condensed RNPs, i.e., RNPs surrounded by M
protein, already assume the skeleton-like structure intracellularly
and not much change in shape is required during envelopment and
budding. Thus, the way that RNPs of negative-strand RNA viruses are
condensed by their M proteins may be the basis for morphological
variation and efficiency of virion release.
Interestingly, more than 98% of SAD
M infectious particles
were cell associated, compared to fewer than 10% for SAD L16. This suggests that the assembly intermediates found in fraction 6 of
SAD
M-infected cells were not competent for envelopment with the
plasma membrane. The released SAD
M infectious particles, although
heterogenous in size, have a density that is similar to that of
wild-type RV, indicating that they are also composed of enveloped RNPs
but in an uncondensed form. Such uncondensed RNPs might be enwrapped in
G-containing membranes and released into the supernatant. Since
rhabdovirus G proteins were shown to autonomously mobilize
even unrelated RNAs or RNPs (21, 25), this process of SAD
M particle release does not represent the normal virus budding
mechanism. We assume that the long rod-shaped particles contain
uncondensed RNPs and constitute all free infectious SAD
M particles.
However, we cannot rule out the possibility that some of the G
protein-containing round vesicles may also contain RNP-like
structures, since particles both with and without electron-dense
content were observed (Fig. 7C). The complete absence of bullet-shaped
particles in supernatants of SAD
M-infected cells, however, shows
the absolute requirement of M protein for the characteristic
rhabdovirus morphology. Furthermore, after transient expression of
RV M protein in cells that were infected by SAD
M,
the majority of released particles had the typical bullet-shape
morphology. The titer in the supernatant was also raised 10,000-fold,
clearly showing the central role of rhabdovirus M proteins in both
virus morphogenesis and the budding process.
For efficient budding of RV, a concerted action of both the core (i.e.,
RNPs surrounded by M protein) and the spike protein was
demonstrated to be essential (21). In addition, the RV G cytoplasmic tail was shown to contain a signal to direct
efficient incorporation of not only G but also chimeric proteins
with foreign transmembrane domains and ectodomains into the envelopes
of budding virions (19-21). These data suggested that the
RV G cytoplasmic tail specifically interacts with one or more internal
virus proteins to facilitate both sorting of surface proteins
into virus envelopes and efficient budding. The present results
indicate that M is the only internal virus protein with which the G
cytoplasmic tail may interact. The RV nucleocapsid skeleton is
completely covered with M, rendering it inaccessible to antibodies and
probably also to the G cytoplasmic tail. The lack of colocalization of
M-less RNPs and G protein in SAD
M gradients further
supports the idea that the G cytoplasmic tails interact solely with RV
M localized between the membrane and the nucleocapsid. This is further
supported by the finding of colocalization between M-RNP and G in the
wild-type RV (Fig. 5) as well as of cosedimentation of M and G in the
absence of any other viral protein (Fig. 6). Obviously, the
interaction between G and the RNP complex is mediated by the M layer,
allowing efficient release of infectious progeny virions.
In striking contrast to RV, the closely related VSV appears to utilize
a nonspecific way of incorporating VSV G protein (28) or
heterologous surface proteins (29, 32) into the
envelope. For instance, the human transmembrane protein CD4 was
found to be incorporated into the virus envelope with the same
efficiency as a chimeric CD4 containing the transmembrane and
cytoplasmic domains of VSV G (29, 32). In contrast to the
case for VSV, CD4 and the human chemokine receptor CXCR4 proteins
were efficiently incorporated into an RV-derived envelope only when
the autologous G tail was present (20, 30). We have shown
here that the M protein of RV interacts with G and is thus
responsible for recruiting G protein into the virus. We are now
identifying the residues of the cytoplasmic tail responsible for this
interaction (unpublished data). A direct interaction of VSV M and VSV G
has so far not been shown unequivocally (4, 17). If the
localization of VSV M is considered to be RV-like, the compelling
differences in spike protein incorporation by VSV and RV might be
explained by a less stringent and weaker interaction between M and G. If VSV M is considered to be only inside the RNP, as suggested recently (1), a basic difference in the assembly mechanisms of RV and VSV has to be postulated. In such a situation, M-G interactions would
perhaps not be relevant, and this might be reflected by the observed
nonselective incorporation of VSV surface proteins. Only some
M protein protruding from the ends of RNPs would remain able to
contact G-containing membranes. Moreover, a localization of M
protein in VSV inside the RNP coil would require a substantially modified model of how efficient budding is achieved.
 |
ACKNOWLEDGMENTS |
We thank K. Kegreiss, V. Schlatt, and K. Mildner for their
perfect technical assistance and W. Kramer for the photographic work.
This work was supported by grant BEO/0311171 from the
Bundesministerium für Forschung und Technologie.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Federal Research
Centre for Virus Diseases of Animals, Paul-Ehrlich-Strasse 28, D-72076 Tübingen, Germany. Phone: 49 7071 967 205. Fax: 49 7071 967303. E-mail: conzelmann{at}tue.bfav.de.
Present address: Intervet International b.v., NL-5830 AA
Boxmeer, The Netherlands.
 |
REFERENCES |
| 1.
|
Barge, A.,
Y. Gaudin,
P. Coulon, and R. W. Ruigrok.
1993.
Vesicular stomatitis virus M protein may be inside the ribonucleocapsid coil.
J. Virol.
67:7246-7253[Abstract/Free Full Text].
|
| 2.
|
Carroll, A. R., and R. R. Wagner.
1979.
Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.
J. Virol.
29:134-142[Abstract/Free Full Text].
|
| 3.
|
Cartwright, B.,
C. J. Smale, and F. Brown.
1970.
Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components.
J. Gen. Virol.
7:19-32[Abstract/Free Full Text].
|
| 4.
|
Chong, L. D., and J. K. Rose.
1993.
Membrane association of functional vesicular stomatitis virus matrix protein in vivo.
J. Virol.
67:407-414[Abstract/Free Full Text].
|
| 5.
|
Chong, L. D., and J. K. Rose.
1994.
Interactions of normal and mutant vesicular stomatitis virus matrix proteins with the plasma membrane and nucleocapsids.
J. Virol.
68:441-447[Abstract/Free Full Text].
|
| 6.
|
Clinton, G. M.,
S. P. Little,
F. S. Hagen, and A. S. Huang.
1978.
The matrix (M) protein of vesicular stomatitis virus regulates transcription.
Cell
15:1455-1462[Medline].
|
| 7.
|
Conzelmann, K. K.,
J. H. Cox,
L. G. Schneider, and H. J. Thiel.
1990.
Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19.
Virology
175:485-499[Medline].
|
| 8.
|
Conzelmann, K. K.,
J. H. Cox, and H. J. Thiel.
1991.
An L (polymerase)-deficient rabies virus defective interfering particle RNA is replicated and transcribed by heterologous helper virus L proteins.
Virology
184:655-663[Medline].
|
| 9.
|
Conzelmann, K. K., and G. Meyers.
1996.
Genetic engineering of animal RNA viruses.
Trends Microbiol.
4:386-393[Medline].
|
| 10.
|
Conzelmann, K. K., and M. Schnell.
1994.
Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins.
J. Virol.
68:713-719[Abstract/Free Full Text].
|
| 11.
|
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126[Abstract/Free Full Text].
|
| 12.
|
Ito, Y.,
A. Nishizono,
K. Mannen,
K. Hiramatsu, and K. Mifune.
1996.
Rabies virus M protein expressed in Escherichia coli and its regulatory role in virion-associated transcriptase activity.
Arch. Virol.
141:671-683[Medline].
|
| 13.
|
Justice, P. A.,
W. Sun,
Y. Li,
Z. Ye,
P. R. Grigera, and R. R. Wagner.
1995.
Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus.
J. Virol.
69:3156-3160[Abstract].
|
| 14.
|
Lenard, J.
1996.
Negative-strand virus M and retrovirus MA proteins: all in a family?
Virology
216:289-298[Medline].
|
| 15.
|
Li, Y.,
L. Luo,
M. Schubert,
R. R. Wagner, and C. Y. Kang.
1993.
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus.
J. Virol.
67:4415-4420[Abstract/Free Full Text].
|
| 16.
|
Lyles, D. S.,
M. McKenzie,
P. E. Kaptur,
K. W. Grant, and W. G. Jerome.
1996.
Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes.
Virology
217:76-87[Medline].
|
| 17.
|
Lyles, D. S.,
M. McKenzie, and J. W. Parce.
1992.
Subunit interactions of vesicular stomatitis virus envelope glycoprotein stabilized by binding to viral matrix protein.
J. Virol.
66:349-358[Abstract/Free Full Text].
|
| 18.
|
Marx, P. A.,
A. Portner, and D. W. Kingsbury.
1974.
Sendai virion transcriptase complex: polypeptide composition and inhibition by virion envelope proteins.
J. Virol.
13:107-112[Abstract/Free Full Text].
|
| 19.
|
Mebatsion, T., and K. K. Conzelmann.
1996.
Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein.
Proc. Natl. Acad. Sci. USA
93:11366-11370[Abstract/Free Full Text].
|
| 20.
|
Mebatsion, T.,
S. Finke,
F. Weiland, and K. K. Conzelmann.
1997.
A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells.
Cell
90:841-847[Medline].
|
| 21.
|
Mebatsion, T.,
M. König, and K. Conzelmann.
1996.
Budding of rabies virus particles in the absence of the spike glycoprotein.
Cell
84:941-951[Medline].
|
| 22.
|
Newcomb, W. W., and J. C. Brown.
1981.
Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions.
J. Virol.
39:295-299[Abstract/Free Full Text].
|
| 23.
|
Ni, Y.,
Y. Iwatani,
K. Morimoto, and A. Kawai.
1996.
Studies on unusual cytoplasmic structures which contain rabies virus envelope proteins.
J. Gen. Virol.
77:2137-2147[Abstract/Free Full Text].
|
| 24.
|
Odenwald, W. F.,
H. Arnheiter,
M. Dubois-Dalcq, and R. A. Lazzarini.
1986.
Stereo images of vesicular stomatitis virus assembly.
J. Virol.
57:922-932[Abstract/Free Full Text].
|
| 25.
|
Rolls, M. M.,
P. Webster,
N. H. Balba, and J. K. Rose.
1994.
Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA.
Cell
79:497-506[Medline].
|
| 26.
|
Ruigrok, R. W.,
L. J. Calder, and S. A. Wharton.
1989.
Electron microscopy of the influenza virus submembranal structure.
Virology
173:311-316[Medline].
|
| 27.
|
Schneider, L., and S. Meyers.
1981.
Antigenic determinants of rabies virus as demonstrated by monoclonal antibody, p. 947-953.
In
D. H. L. Bishop, and R. W. Compans (ed.), The replication of negative strand RNA viruses. Elsevier, Amsterdam, The Netherlands.
|
| 28.
|
Schnell, M. J.,
L. Buonocore,
E. Botitz,
H. P. Ghosh,
R. Chernish, and J. K. Rose.
1998.
Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus.
EMBO J.
17:1289-1296[Medline].
|
| 29.
|
Schnell, M. J.,
L. Buonocore,
E. Kretzschmar,
E. Johnson, and J. K. Rose.
1996.
Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
Proc. Natl. Acad. Sci. USA
93:11359-11365[Abstract/Free Full Text].
|
| 30.
|
Schnell, M. J.,
J. E. Johnson,
L. Buonocore, and J. K. Rose.
1997.
Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection.
Cell
90:849-857[Medline].
|
| 31.
|
Schnell, M. J.,
T. Mebatsion, and K. K. Conzelmann.
1994.
Infectious rabies viruses from cloned cDNA.
EMBO J.
13:4195-4203[Medline].
|
| 32.
|
Schubert, M.,
B. Joshi,
D. Blondel, and G. G. Harmison.
1992.
Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles.
J. Virol.
66:1579-1589[Abstract/Free Full Text].
|
| 33.
|
Simons, K., and H. Garoff.
1980.
The budding mechanisms of enveloped animal viruses.
J. Gen. Virol.
50:1-21[Abstract/Free Full Text].
|
| 34.
|
Smirnov, Y. A.,
M. A. Kuznetsova, and N. V. Kaverin.
1991.
The genetic aspects of influenza virus filamentous particle formation.
Arch. Virol.
118:279-284[Medline].
|
| 35.
|
Suryanarayana, K.,
K. Baczko,
V. ter Meulen, and R. R. Wagner.
1994.
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue.
J. Virol.
68:1532-1543[Abstract/Free Full Text].
|
| 36.
|
Thoulouze, M. I.,
M. Lafage,
J. A. Montano-Hirose, and M. Lafon.
1997.
Rabies virus infects mouse and human lymphocytes and induces apoptosis.
J. Virol.
71:7372-7380[Abstract].
|
| 37.
|
Zvonarjev, A. Y., and Y. Z. Ghendon.
1980.
Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine.
J. Virol.
33:583-586[Abstract/Free Full Text].
|
Journal of Virology, January 1999, p. 242-250, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Casabona, J. C., Levingston Macleod, J. M., Loureiro, M. E., Gomez, G. A., Lopez, N.
(2009). The RING Domain and the L79 Residue of Z Protein Are Involved in both the Rescue of Nucleocapsids and the Incorporation of Glycoproteins into Infectious Chimeric Arenavirus-Like Particles. J. Virol.
83: 7029-7039
[Abstract]
[Full Text]
-
Das, S. C., Panda, D., Nayak, D., Pattnaik, A. K.
(2009). Biarsenical Labeling of Vesicular Stomatitis Virus Encoding Tetracysteine-Tagged M Protein Allows Dynamic Imaging of M Protein and Virus Uncoating in Infected Cells. J. Virol.
83: 2611-2622
[Abstract]
[Full Text]
-
Wirblich, C., Tan, G. S., Papaneri, A., Godlewski, P. J., Orenstein, J. M., Harty, R. N., Schnell, M. J.
(2008). PPEY Motif within the Rabies Virus (RV) Matrix Protein Is Essential for Efficient Virion Release and RV Pathogenicity. J. Virol.
82: 9730-9738
[Abstract]
[Full Text]
-
Utley, T. J., Ducharme, N. A., Varthakavi, V., Shepherd, B. E., Santangelo, P. J., Lindquist, M. E., Goldenring, J. R., Crowe, J. E. Jr.
(2008). Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc. Natl. Acad. Sci. USA
105: 10209-10214
[Abstract]
[Full Text]
-
Gholami, A., Kassis, R., Real, E., Delmas, O., Guadagnini, S., Larrous, F., Obach, D., Prevost, M.-C., Jacob, Y., Bourhy, H.
(2008). Mitochondrial Dysfunction in Lyssavirus-Induced Apoptosis. J. Virol.
82: 4774-4784
[Abstract]
[Full Text]
-
Pulmanausahakul, R., Li, J., Schnell, M. J., Dietzschold, B.
(2008). The Glycoprotein and the Matrix Protein of Rabies Virus Affect Pathogenicity by Regulating Viral Replication and Facilitating Cell-to-Cell Spread. J. Virol.
82: 2330-2338
[Abstract]
[Full Text]
-
Klingen, Y., Conzelmann, K.-K., Finke, S.
(2008). Double-Labeled Rabies Virus: Live Tracking of Enveloped Virus Transport. J. Virol.
82: 237-245
[Abstract]
[Full Text]
-
Chen, B. J., Leser, G. P., Morita, E., Lamb, R. A.
(2007). Influenza Virus Hemagglutinin and Neuraminidase, but Not the Matrix Protein, Are Required for Assembly and Budding of Plasmid-Derived Virus-Like Particles. J. Virol.
81: 7111-7123
[Abstract]
[Full Text]
-
Mittler, E., Kolesnikova, L., Strecker, T., Garten, W., Becker, S.
(2007). Role of the Transmembrane Domain of Marburg Virus Surface Protein GP in Assembly of the Viral Envelope. J. Virol.
81: 3942-3948
[Abstract]
[Full Text]
-
Marston, D. A., McElhinney, L. M., Johnson, N., Muller, T., Conzelmann, K. K., Tordo, N., Fooks, A. R.
(2007). Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region. J. Gen. Virol.
88: 1302-1314
[Abstract]
[Full Text]
-
Komarova, A. V., Real, E., Borman, A. M., Brocard, M., England, P., Tordo, N., Hershey, J. W.B., Kean, K. M., Jacob, Y.
(2007). Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis. Nucleic Acids Res
35: 1522-1532
[Abstract]
[Full Text]
-
Pantua, H. D., McGinnes, L. W., Peeples, M. E., Morrison, T. G.
(2006). Requirements for the Assembly and Release of Newcastle Disease Virus-Like Particles. J. Virol.
80: 11062-11073
[Abstract]
[Full Text]
-
Nagarajan, T., Mohanasubramanian, B., Seshagiri, E. V., Nagendrakumar, S. B., Saseendranath, M. R., Satyanarayana, M. L., Thiagarajan, D., Rangarajan, P. N., Srinivasan, V. A.
(2006). Molecular epidemiology of rabies virus isolates in India.. J. Clin. Microbiol.
44: 3218-3224
[Abstract]
[Full Text]
-
Mahapatra, M., Parida, S., Baron, M. D., Barrett, T.
(2006). Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex. J. Gen. Virol.
87: 2021-2029
[Abstract]
[Full Text]
-
Solon, J., Gareil, O., Bassereau, P., Gaudin, Y.
(2005). Membrane deformations induced by the matrix protein of vesicular stomatitis virus in a minimal system. J. Gen. Virol.
86: 3357-3363
[Abstract]
[Full Text]
-
Faber, M., Faber, M.-L., Papaneri, A., Bette, M., Weihe, E., Dietzschold, B., Schnell, M. J.
(2005). A Single Amino Acid Change in Rabies Virus Glycoprotein Increases Virus Spread and Enhances Virus Pathogenicity. J. Virol.
79: 14141-14148
[Abstract]
[Full Text]
-
Perez, M., de la Torre, J. C.
(2005). Identification of the Borna disease virus (BDV) proteins required for the formation of BDV-like particles. J. Gen. Virol.
86: 1891-1895
[Abstract]
[Full Text]
-
Bourmakina, S. V., Garcia-Sastre, A.
(2005). The Morphology and Composition of Influenza A Virus Particles Are Not Affected by Low Levels of M1 and M2 Proteins in Infected Cells. J. Virol.
79: 7926-7932
[Abstract]
[Full Text]
-
Faber, M., Pulmanausahakul, R., Nagao, K., Prosniak, M., Rice, A. B., Koprowski, H., Schnell, M. J., Dietzschold, B.
(2004). Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. USA
101: 16328-16332
[Abstract]
[Full Text]
-
Finke, S., Brzozka, K., Conzelmann, K.-K.
(2004). Tracking Fluorescence-Labeled Rabies Virus: Enhanced Green Fluorescent Protein-Tagged Phosphoprotein P Supports Virus Gene Expression and Formation of Infectious Particles. J. Virol.
78: 12333-12343
[Abstract]
[Full Text]
-
Koser, M. L., McGettigan, J. P., Tan, G. S., Smith, M. E., Koprowski, H., Dietzschold, B., Schnell, M. J.
(2004). Rabies virus nucleoprotein as a carrier for foreign antigens. Proc. Natl. Acad. Sci. USA
101: 9405-9410
[Abstract]
[Full Text]
-
Kassis, R., Larrous, F., Estaquier, J., Bourhy, H.
(2004). Lyssavirus Matrix Protein Induces Apoptosis by a TRAIL-Dependent Mechanism Involving Caspase-8 Activation. J. Virol.
78: 6543-6555
[Abstract]
[Full Text]
-
Kolesnikova, L., Bamberg, S., Berghofer, B., Becker, S.
(2004). The Matrix Protein of Marburg Virus Is Transported to the Plasma Membrane along Cellular Membranes: Exploiting the Retrograde Late Endosomal Pathway. J. Virol.
78: 2382-2393
[Abstract]
[Full Text]
-
Mas, V., Rocha, A., Perez, L., Coll, J. M., Estepa, A.
(2004). Reversible Inhibition of Spreading of In Vitro Infection and Imbalance of Viral Protein Accumulation at Low pH in Viral Hemorrhagic Septicemia Rhabdovirus, a Salmonid Rhabdovirus. J. Virol.
78: 1936-1944
[Abstract]
[Full Text]
-
Finke, S., Conzelmann, K.-K.
(2003). Dissociation of Rabies Virus Matrix Protein Functions in Regulation of Viral RNA Synthesis and Virus Assembly. J. Virol.
77: 12074-12082
[Abstract]
[Full Text]
-
McGettigan, J. P., Naper, K., Orenstein, J., Koser, M., McKenna, P. M., Schnell, M. J.
(2003). Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome. J. Virol.
77: 10889-10899
[Abstract]
[Full Text]
-
Finke, S., Mueller-Waldeck, R., Conzelmann, K.-K.
(2003). Rabies virus matrix protein regulates the balance of virus transcription and replication. J. Gen. Virol.
84: 1613-1621
[Abstract]
[Full Text]
-
Inoue, M., Tokusumi, Y., Ban, H., Kanaya, T., Shirakura, M., Tokusumi, T., Hirata, T., Nagai, Y., Iida, A., Hasegawa, M.
(2003). A New Sendai Virus Vector Deficient in the Matrix Gene Does Not Form Virus Particles and Shows Extensive Cell-to-Cell Spreading. J. Virol.
77: 6419-6429
[Abstract]
[Full Text]
-
McGettigan, J. P., Pomerantz, R. J., Siler, C. A., McKenna, P. M., Foley, H. D., Dietzschold, B., Schnell, M. J.
(2002). Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic. J. Virol.
77: 237-244
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Waning, D. L., Schmitt, A. P., Leser, G. P., Lamb, R. A.
(2002). Roles for the Cytoplasmic Tails of the Fusion and Hemagglutinin-Neuraminidase Proteins in Budding of the Paramyxovirus Simian Virus 5. J. Virol.
76: 9284-9297
[Abstract]
[Full Text]
-
Noda, T., Sagara, H., Suzuki, E., Takada, A., Kida, H., Kawaoka, Y.
(2002). Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP. J. Virol.
76: 4855-4865
[Abstract]
[Full Text]
-
Schmitt, A. P., Leser, G. P., Waning, D. L., Lamb, R. A.
(2002). Requirements for Budding of Paramyxovirus Simian Virus 5 Virus-Like Particles. J. Virol.
76: 3952-3964
[Abstract]
[Full Text]
-
Faber, M., Pulmanausahakul, R., Hodawadekar, S. S., Spitsin, S., McGettigan, J. P., Schnell, M. J., Dietzschold, B.
(2002). Overexpression of the Rabies Virus Glycoprotein Results in Enhancement of Apoptosis and Antiviral Immune Response. J. Virol.
76: 3374-3381
[Abstract]
[Full Text]
-
Foley, H. D., Otero, M., Orenstein, J. M., Pomerantz, R. J., Schnell, M. J.
(2002). Rhabdovirus-Based Vectors with Human Immunodeficiency Virus Type 1 (HIV-1) Envelopes Display HIV-1-Like Tropism and Target Human Dendritic Cells. J. Virol.
76: 19-31
[Abstract]
[Full Text]
-
Tuffereau, C., Desmezieres, E., Benejean, J., Jallet, C., Flamand, A., Tordo, N., Perrin, P.
(2001). Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR. J. Gen. Virol.
82: 2861-2867
[Abstract]
[Full Text]
-
Mebatsion, T.
(2001). Extensive Attenuation of Rabies Virus by Simultaneously Modifying the Dynein Light Chain Binding Site in the P Protein and Replacing Arg333 in the G Protein. J. Virol.
75: 11496-11502
[Abstract]
[Full Text]
-
Harty, R. N., Brown, M. E., McGettigan, J. P., Wang, G., Jayakar, H. R., Huibregtse, J. M., Whitt, M. A., Schnell, M. J.
(2001). Rhabdoviruses and the Cellular Ubiquitin-Proteasome System: a Budding Interaction. J. Virol.
75: 10623-10629
[Abstract]
[Full Text]
-
Badrane, H., Tordo, N.
(2001). Host Switching in Lyssavirus History from the Chiroptera to the Carnivora Orders. J. Virol.
75: 8096-8104
[Abstract]
[Full Text]
-
Badrane, H., Bahloul, C., Perrin, P., Tordo, N.
(2001). Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity. J. Virol.
75: 3268-3276
[Abstract]
[Full Text]
-
Escors, D., Ortego, J., Laude, H., Enjuanes, L.
(2001). The Membrane M Protein Carboxy Terminus Binds to Transmissible Gastroenteritis Coronavirus Core and Contributes to Core Stability. J. Virol.
75: 1312-1324
[Abstract]
[Full Text]
-
Gómez-Puertas, P., Albo, C., Pérez-Pastrana, E., Vivo, A., Portela, A.
(2000). Influenza Virus Matrix Protein Is the Major Driving Force in Virus Budding. J. Virol.
74: 11538-11547
[Abstract]
[Full Text]
-
Foley, H. D., McGettigan, J. P., Siler, C. A., Dietzschold, B., Schnell, M. J.
(2000). A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc. Natl. Acad. Sci. USA
10.1073/pnas.011510698v1
[Abstract]
[Full Text]
-
Buchholz, U. J., Granzow, H., Schuldt, K., Whitehead, S. S., Murphy, B. R., Collins, P. L.
(2000). Chimeric Bovine Respiratory Syncytial Virus with Glycoprotein Gene Substitutions from Human Respiratory Syncytial Virus (HRSV): Effects on Host Range and Evaluation as a Live-Attenuated HRSV Vaccine. J. Virol.
74: 1187-1199
[Abstract]
[Full Text]
-
Godeke, G.-J., de Haan, C. A. M., Rossen, J. W. A., Vennema, H., Rottier, P. J. M.
(2000). Assembly of Spikes into Coronavirus Particles Is Mediated by the Carboxy-Terminal Domain of the Spike Protein. J. Virol.
74: 1566-1571
[Abstract]
[Full Text]
-
Foley, H. D., McGettigan, J. P., Siler, C. A., Dietzschold, B., Schnell, M. J.
(2000). A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc. Natl. Acad. Sci. USA
97: 14680-14685
[Abstract]
[Full Text]